What Researchers Did
Researchers reported on a 17-year-old male gymnast with stage IIIA Kienböck's disease who underwent 120 sessions of hyperbaric oxygen therapy after declining surgical treatment.
What They Found
After 120 sessions of hyperbaric oxygen therapy, the patient showed favorable clinical and radiological evolution by April 2018. This included improved pain, motion, and strength, alongside an almost complete resolution of aseptic necrosis of the lunate bone.
What This Means for Canadian Patients
This case suggests that hyperbaric oxygen therapy could be an experimental treatment option for Kienböck's disease, particularly for patients who decline or fail conventional treatments. However, this is a single case report, and further studies are required to determine its broader applicability and efficacy.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this study is that it is a single case report, which limits the generalizability of its findings.